(NNE) Nano Nuclear Energy Common - Overview

Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NASDAQ (USA) | Market Cap: 1.258m USD | Total Return: -23.4% in 12m

Microreactors, Nuclear Fuel, Fuel Transportation, Consulting
Total Rating 22
Safety 64
Buy Signal -0.24
Specialty Industrial Machinery
Industry Rotation: -8.7
Market Cap: 1.26B
Avg Turnover: 50.8M
Risk 3d forecast
Volatility109%
VaR 5th Pctl17.2%
VaR vs Median-4.85%
Reward TTM
Sharpe Ratio0.42
Rel. Str. IBD19.6
Rel. Str. Peer Group3.8
Character TTM
Beta3.990
Beta Downside4.000
Hurst Exponent0.435
Drawdowns 3y
Max DD77.68%
CAGR/Max DD1.52
CAGR/Mean DD3.30

Warnings

Share dilution 39.3% YoY

High Debt while negative Cash Flow

Altman Z'' -4.61 < 1.0 - financial distress zone

Choppy

Tailwinds

No distinct edge detected

Description: NNE Nano Nuclear Energy Common

NANO Nuclear Energy Inc. is a New York-based nuclear technology firm focused on the development of portable microreactors and the nuclear fuel supply chain. Its primary projects include the KRONOS and LOKI high-temperature gas-cooled reactors, the ZEUS solid core battery reactor, and the ODIN low-pressure salt coolant reactor. The company’s business model extends beyond power generation to include HALEU (high-assay low-enriched uranium) fuel processing, transportation logistics, and specialized nuclear consultancy services.

The microreactor sector aims to provide carbon-free energy to remote locations, military installations, and industrial sites where traditional grid access is unavailable. Unlike large-scale light-water reactors, these compact systems are designed for factory fabrication and rapid deployment via standard shipping methods. Investors can find further data on these emerging energy technologies through the ValueRay platform. Since its incorporation in 2022, NNE has positioned itself to address the fuel supply bottleneck currently facing the next generation of advanced nuclear reactor designs.

Headlines to Watch Out For
  • Milestones in KRONOS and LOKI microreactor prototyping drive investor sentiment
  • HALEU fuel fabrication facility development secures vertical integration and revenue
  • Regulatory approval progress for portable nuclear designs impacts market valuation
  • Government contracts and Department of Energy funding influence capital expenditure
  • Strategic partnerships for nuclear fuel transportation expand long-term service margins
Piotroski VR-10 (Strict) 0.0
Net Income: error (cannot be calculated; needs Net Income TTM and Revenue TTM)
FCF/TA: -0.06 > 0.02 and ΔFCF/TA 5.19 > 1.0
NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev)
CFO/TA -0.04 > 3% & CFO -23.3m > Net Income -31.3m
Net Debt/EBITDA: error (EBITDA <= 0)
Current Ratio: 95.72 > 1.5 & < 3
Outstanding Shares: last quarter (51.6m) vs 12m ago 39.31% < -2%
Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin)
Asset Turnover: 0.0% > 50% (prev 0.06%; Δ -0.06% > 0%)
Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM)
Altman Z'' -4.61
A: 0.94 (Total Current Assets 571.7m - Total Current Liabilities 5.97m) / Total Assets 603.9m
B: -0.12 (Retained Earnings -73.2m / Total Assets 603.9m)
C: -0.12 (EBIT TTM -43.6m / Avg Total Assets 371.4m)
D: -9.12 (Book Value of Equity -73.2m / Total Liabilities 8.03m)
Altman-Z'' = -4.61 = D
What is the price of NNE shares?

As of May 25, 2026, the stock is trading at USD 25.08 with a total of 1,633,778 shares traded.
Over the past week, the price has changed by +7.26%, over one month by +9.12%, over three months by +5.15% and over the past year by -23.39%.

Is NNE a buy, sell or hold?

Nano Nuclear Energy Common has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy NNE.

  • StrongBuy: 1
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the NNE price?
Analysts Target Price 46.7 86.1%
Nano Nuclear Energy Common (NNE) - Fundamental Data Overview as of 21 May 2026
P/B = 2.1108
Revenue TTM = 0.0 USD
EBIT TTM = -43.6m USD
EBITDA TTM = -42.5m USD
Long Term Debt = 2.05m USD (estimated: total debt 2.60m - short term 547k)
Short Term Debt = 547k USD (from shortTermDebt, last quarter)
Debt = 2.60m USD (from shortLongTermDebtTotal, last quarter) (leases 2.60m already included)
Net Debt = -566.1m USD (calculated: Debt 2.60m - CCE 568.7m)
Enterprise Value = 691.7m USD (1.26b + Debt 2.60m - CCE 568.7m)
 Interest Coverage Ratio = unknown (Ebit TTM -43.6m / Interest Expense TTM 0.0)
 EV/FCF = -18.06x (Enterprise Value 691.7m / FCF TTM -38.3m)
FCF Yield = -5.54% (FCF TTM -38.3m / Enterprise Value 691.7m)
 FCF Margin = unknown (Revenue TTM is 0 or missing)
 Net Margin = unknown
 Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 1.10m) / Revenue TTM)
 Tobins Q-Ratio = 1.15 (Enterprise Value 691.7m / Total Assets 603.9m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 2.60m)
Taxrate = 21.0% (US default 21%)
NOPAT = -34.4m (EBIT -43.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 95.72 (Total Current Assets 571.7m / Total Current Liabilities 5.97m)
Debt / Equity = 0.00 (Debt 2.60m / totalStockholderEquity, last quarter 595.9m)
 Debt / EBITDA = 13.33 (negative EBITDA) (Net Debt -566.1m / EBITDA -42.5m)
 Debt / FCF = 14.78 (negative FCF - burning cash) (Net Debt -566.1m / FCF TTM -38.3m)
 Total Stockholder Equity = 411.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.44% (Net Income -31.3m / Total Assets 603.9m)
RoE = -6.47% (Net Income TTM -31.3m / Total Stockholder Equity 484.3m)
RoCE = -8.96% (EBIT -43.6m / Capital Employed (Equity 484.3m + L.T.Debt 2.05m))
 RoIC = -5.81% (negative operating profit) (NOPAT -34.4m / Invested Capital 592.6m)
 WACC = 19.98% (E(1.26b)/V(1.26b) * Re(20.02%) + D(2.60m)/V(1.26b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 20.02% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 98.88 | Cagr: 42.76%
 [DCF] Fair Price = unknown (Cash Flow -38.3m)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: 2.45 | # QB: 1
Revenue Correlation: N/A | Revenue CAGR: N/A | SUE: 0.0 | # QB: 0
EPS current Quarter (2026-06-30): EPS=-0.28 | Chg30d=+11.29% | Revisions=+0% | Analysts=4
EPS current Year (2026-09-30): EPS=-0.93 | Chg30d=+14.55% | Revisions=+33% | GrowthEPS=+12.7% | GrowthRev=+0.0%
EPS next Year (2027-09-30): EPS=-1.40 | Chg30d=+3.29% | Revisions=-33% | GrowthEPS=-50.8% | GrowthRev=+0.0%
[Analyst] Revisions Ratio: +33%